Visionary Secures US$12M China Deal, Divests Education Unit to Sharpen Aesthetics Focus
Visionary Health Technology Group signed a US$12 million exclusive distribution deal with Huajin China for its Premier Regenerative Complex–President Super Injection, targeting US$12 million sales in 12 months. The Board approved sale of Visionary Education Services & Management Inc., refocusing resources on high-margin medical aesthetics and biotech innovation.
1. Exclusive US$12 Million China Distribution Deal
Visionary Health Technology Group signed a US$12 million exclusive distribution deal with Huajin China for its Premier Regenerative Complex–President Super Injection, targeting US$12 million in sales over 12 months; revenue will be recognized upon product delivery, customer acceptance and compliance with accounting standards.
2. Divestiture of Non-Core Education Services
On February 27, the Board approved the sale of Visionary Education Services & Management Inc. to Cai Dao Trading Ltd., completing the exit from non-core operations and enabling a leaner corporate structure.
3. Refocused Business Strategy and Growth Outlook
The company will allocate resources exclusively to high-margin anti-aging injectables, regenerative medical aesthetics and biotech-driven healthcare innovation, entering a commercialization acceleration phase aimed at improving revenue visibility and capital efficiency.